166 related articles for article (PubMed ID: 15297654)
1. Immunology. NK cells lose their inhibition.
Parham P
Science; 2004 Aug; 305(5685):786-7. PubMed ID: 15297654
[No Abstract] [Full Text] [Related]
2. Association of killer immunoglobulin-like receptors and their HLA Class I ligands with progression of chronic hepatitis C virus infection.
López-Vázquez A; Rodrigo L; López-Larrea C
Tissue Antigens; 2007 Apr; 69 Suppl 1():241-2. PubMed ID: 17445210
[TBL] [Abstract][Full Text] [Related]
3. Influence of inhibitory killer immunoglobulin-like receptors and their HLA-C ligands on resolving hepatitis C virus infection.
Rauch A; Laird R; McKinnon E; Telenti A; Furrer H; Weber R; Smillie D; Gaudieri S;
Tissue Antigens; 2007 Apr; 69 Suppl 1():237-40. PubMed ID: 17445209
[TBL] [Abstract][Full Text] [Related]
4. HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection.
Khakoo SI; Thio CL; Martin MP; Brooks CR; Gao X; Astemborski J; Cheng J; Goedert JJ; Vlahov D; Hilgartner M; Cox S; Little AM; Alexander GJ; Cramp ME; O'Brien SJ; Rosenberg WM; Thomas DL; Carrington M
Science; 2004 Aug; 305(5685):872-4. PubMed ID: 15297676
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis C virus and the threshold of natural killer cell inhibition.
Ahlenstiel G; Rehermann B
Hepatology; 2005 Mar; 41(3):675-7. PubMed ID: 15723330
[No Abstract] [Full Text] [Related]
6. Killer cell immunoglobulin-like receptor genotype and killer cell immunoglobulin-like receptor-human leukocyte antigen C ligand compatibility affect the severity of hepatitis C virus recurrence after liver transplantation.
de Arias AE; Haworth SE; Belli LS; Burra P; Pinzello G; Vangeli M; Minola E; Guido M; Boccagni P; De Feo TM; Torelli R; Cardillo M; Scalamogna M; Poli F
Liver Transpl; 2009 Apr; 15(4):390-9. PubMed ID: 19326408
[TBL] [Abstract][Full Text] [Related]
7. KIR genes and their human leukocyte antigen ligands in the progression to cirrhosis in patients with chronic hepatitis C.
Marangon AV; Silva GF; de Moraes CF; Grotto RM; Pardini MI; de Pauli DS; Sell AM; Visentainer JE; Moliterno RA
Hum Immunol; 2011 Nov; 72(11):1074-8. PubMed ID: 21920398
[TBL] [Abstract][Full Text] [Related]
8. KIR2DS1-mediated activation overrides NKG2A-mediated inhibition in HLA-C C2-negative individuals.
Foley B; De Santis D; Lathbury L; Christiansen F; Witt C
Int Immunol; 2008 Apr; 20(4):555-63. PubMed ID: 18308713
[TBL] [Abstract][Full Text] [Related]
9. Natural killer receptors on CD8 T cells and natural killer cells from different HLA-C phenotypes in melanoma patients.
Campillo JA; Martínez-Escribano JA; Moya-Quiles MR; Marín LA; Muro M; Guerra N; Parrado A; Campos M; Frías JF; Minguela A; García-Alonso AM; Alvarez-López MR
Clin Cancer Res; 2006 Aug; 12(16):4822-31. PubMed ID: 16914567
[TBL] [Abstract][Full Text] [Related]
10. HLA-C and KIR genes in hepatitis C virus infection.
Montes-Cano MA; Caro-Oleas JL; Romero-Gómez M; Diago M; Andrade R; Carmona I; Aguilar Reina J; Núñez-Roldán A; González-Escribano MF
Hum Immunol; 2005 Nov; 66(11):1106-9. PubMed ID: 16571411
[TBL] [Abstract][Full Text] [Related]
11. Associations between KIR epitope combinations expressed by HLA-B/-C haplotypes found in an HIV-1 infected study population may influence NK mediated immune responses.
Gaudieri S; Nolan D; McKinnon E; Witt CS; Mallal S; Christiansen FT
Mol Immunol; 2005 Feb; 42(4):557-60. PubMed ID: 15607813
[TBL] [Abstract][Full Text] [Related]
12. A HLA-Cw6 specific single-chain antibody fragment (scFv) recognizing a natural killer cell receptor epitope.
Marget M; Bohlsen D; Davarnia P; Yoo-Ott K; Kabelitz D; Skerra A; Steinmann J
Mol Immunol; 2005 Mar; 42(5):643-9. PubMed ID: 15607823
[TBL] [Abstract][Full Text] [Related]
13. Evidence for natural killer cell-mediated protection from metastasis formation in uveal melanoma patients.
Maat W; van der Slik AR; Verhoeven DH; Alizadeh BZ; Ly LV; Verduijn W; Luyten GP; Mulder A; van Hall T; Koning F; Jager MJ; van Bergen J
Invest Ophthalmol Vis Sci; 2009 Jun; 50(6):2888-95. PubMed ID: 19234348
[TBL] [Abstract][Full Text] [Related]
14. Killer immunoglobulin-like receptors.
Moretta L; Moretta A
Curr Opin Immunol; 2004 Oct; 16(5):626-33. PubMed ID: 15342010
[TBL] [Abstract][Full Text] [Related]
15. [Immunoediting of natural killer cells by human nasopharyngeal carcinoma cell line: altered expression of KIRs and NKG2D receptors leads to reduction of natural killer cell-mediated cytolysis].
Guo KY; Mei JZ; Yao KT
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Mar; 27(3):247-9. PubMed ID: 17425963
[TBL] [Abstract][Full Text] [Related]
16. Impact of the genetic restriction of virus-specific T-cell responses in hepatitis C virus infection.
Neumann-Haefelin C; Thimme R
Genes Immun; 2007 Apr; 8(3):181-92. PubMed ID: 17230195
[TBL] [Abstract][Full Text] [Related]
17. Immunology. The footprint of a killer.
Kärre K; Schneider G
Nature; 2000 Jun; 405(6786):527-8. PubMed ID: 10850700
[No Abstract] [Full Text] [Related]
18. [Interaction between natural killer (NK) cells and the major histocompatibility system].
Bishara A; Brautbar C; Nagler A
Harefuah; 1996 Mar; 130(5):322-6. PubMed ID: 8707177
[No Abstract] [Full Text] [Related]
19. Human NK cell education by inhibitory receptors for MHC class I.
Anfossi N; André P; Guia S; Falk CS; Roetynck S; Stewart CA; Breso V; Frassati C; Reviron D; Middleton D; Romagné F; Ugolini S; Vivier E
Immunity; 2006 Aug; 25(2):331-42. PubMed ID: 16901727
[TBL] [Abstract][Full Text] [Related]
20. Surface NK receptors and their ligands on tumor cells.
Moretta L; Bottino C; Pende D; Castriconi R; Mingari MC; Moretta A
Semin Immunol; 2006 Jun; 18(3):151-8. PubMed ID: 16730454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]